Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2020 09:00 ET | Source: OpGen, Inc.

OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

Shareholder proxy vote achieves quorum with 99% support for the transaction Final step in OpGen / Curetis business combination achieved pending results of Special Meeting GAITHERSBURG, Md., March ...
March 23, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Data Predicting Phenotypic Antimicrobial Susceptibility Published in Diagnostic Microbiology & Infectious Disease Journal

GAITHERSBURG, Md., March 23, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that its Acuitas Lighthouse® was used in a study conducted by the Mayo Clinic to predict phenotypic...
March 19, 2020 09:00 ET | Source: OpGen, Inc.

OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

GAITHERSBURG, Md., March 19, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat...
March 16, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Provides Update on Curetis Now Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

- Rapid real-time PCR test allows testing for SARS-CoV2 in only a few hours - Test kit to be made available via Curetis’ European sales channels - Synergies with Curetis Unyvero HPN panel for...
March 12, 2020 07:30 ET | Source: OpGen, Inc.

OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2019

GAITHERSBURG, Md., March 12, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will report its fourth quarter and full year 2019...
March 10, 2020 11:00 ET | Source: OpGen, Inc.

Curetis N.V. Shareholders Approve Planned Business Combination with OpGen

Key milestone achieved supporting planned business combination of Curetis Group and OpGenOpGen adjourns Special Meeting to March 30, 2020 GAITHERSBURG, Md., March 10, 2020 (GLOBE NEWSWIRE) --...
February 20, 2020 09:40 ET | Source: OpGen, Inc.

OpGen Provides Update on Curetis Preliminary, Unaudited 2019 Condensed Combined Key Financials and Business Update

Revenue increases by 64% to EUR 2.3 million, up from 1.4 million in 2018 More than tripled total contract order volume received year-over-year to about EUR 3.4 million 2019 Combined revenue for...
February 12, 2020 10:10 ET | Source: OpGen, Inc.

OpGen Announces Preliminary Unaudited Revenue for Fiscal 2019 and Provides Business Update

Total Revenue for 2019 increases 18.7% to $3.5 million, up from $3.0 million in 2018Curetis - OpGen business combination shareholder votes set for March 10, 2020 GAITHERSBURG, Md., Feb. 12, 2020 ...
January 30, 2020 08:21 ET | Source: OpGen, Inc.

OpGen Provides Update on Curetis Group Company Ares Genetics’ Collaboration with BGI Group to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe

BGI Group responds to coronavirus crisis by providing reagent kits for molecular 2019-nCoV testing by next-generation sequencing and RT-PCRAres Genetics to launch next-generation sequencing testing...
January 28, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Achieves Key Milestone in Planned Business Combination with Curetis

Special meetings of OpGen and Curetis shareholders are scheduled for March 10, 2020, at 10:00am ET and 1:00pm CET, respectivelyTransaction unanimously supported by the boards of OpGen and Curetis and...